MAGI

MAGI Award for Excellence in Site Payments winners announced

Monday, June 5, 2017

Nimblify, a clinical trials technology company, helped announce the winners of the MAGI Award for Excellence in Site Payments at MAGI‘s Clinical Research Conference on May 22, 2017 in Philadelphia, Pennsylvania. Nimblify partnered with MAGI to perform an analysis on the state of the industry as it relates to site payments and to honor and recognize sponsors and CROs that pay sites promptly. Site customers of Nimblify’s parent company, Forte Research Systems, contributed data for hundreds of studies across 142 sponsors and CROs with nearly 32,000 payment records. Dr. Wendy Tate, director of Data Analytics at Nimblify, curated and analyzed the data to identify trends and averages in timeliness of payments made to sites.

[Read More]

Three Questions: Norman Goldfarb, MAGI

Monday, May 15, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Norman Goldfarb, chairman of Model Agreements & Guidelines International (MAGI), an organization that has spent a decade promoting the standardization of clinical trial agreements (CTAs) and contract templates that both sites and CROs or sponsors can use to speed study startup. Goldfarb is also editor of The Journal of Clinical Research Best Practices, and managing director of First Clinical Research. In April, the Association of Clinical Research Professionals gave Goldfarb their award for innovation for the MAGI CTA initiative.

[Read More]